USD 1.35
(4.65%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 13.79 Million USD | 223.07% |
2022 | 4.26 Million USD | 51.81% |
2021 | 2.81 Million USD | 160.67% |
2020 | -4.63 Million USD | -693.47% |
2019 | 781 Thousand USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 15.5 Million USD | -5.36% |
2024 Q1 | 16.38 Million USD | 18.8% |
2023 Q1 | 14.04 Million USD | 228.98% |
2023 FY | 13.79 Million USD | 223.07% |
2023 Q4 | 13.79 Million USD | -6.83% |
2023 Q3 | 14.8 Million USD | -1.43% |
2023 Q2 | 15.01 Million USD | 6.94% |
2022 Q2 | -6.8 Million USD | 1.73% |
2022 FY | 4.26 Million USD | 51.81% |
2022 Q1 | -6.92 Million USD | -346.37% |
2022 Q4 | 4.26 Million USD | 375.92% |
2022 Q3 | 897 Thousand USD | 113.18% |
2021 Q1 | -292.58 Thousand USD | 93.69% |
2021 Q4 | 2.81 Million USD | 260.59% |
2021 Q3 | -1.75 Million USD | -4029.13% |
2021 Q2 | -42.4 Thousand USD | 85.51% |
2021 FY | 2.81 Million USD | 160.67% |
2020 Q4 | -4.63 Million USD | -1808.23% |
2020 Q3 | -242.89 Thousand USD | 9.47% |
2020 FY | -4.63 Million USD | -693.47% |
2020 Q2 | -268.31 Thousand USD | 27.05% |
2020 Q1 | -367.78 Thousand USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 FY | 781 Thousand USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
CannBioRx Life Sciences Corp. | -655.73 Thousand USD | 2203.305% |
BIMI International Medical Inc. | 3.11 Million USD | -342.235% |
China Jo-Jo Drugstores, Inc. | 10.34 Million USD | -33.31% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | 116.41 Million USD | 88.153% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 109.08 Million USD | 87.357% |
Leafly Holdings, Inc. | 13.79 Million USD | 0.0% |
LifeMD, Inc. | -14.21 Million USD | 197.029% |
LifeMD, Inc. | -14.21 Million USD | 197.029% |
TRxADE HEALTH, Inc. | 6.95 Million USD | -98.389% |
PetMed Express, Inc. | -53.84 Million USD | 125.616% |
Walgreens Boots Alliance, Inc. | 8.23 Billion USD | 99.833% |